Observing the health management of patients with rare genetic syndromes
Official title: GROWing Up With Rare GENEtic Syndromes ….When Children With Complex Genetic Syndromes Reach Adult Age
Run by Erasmus Medical Center · NCT04463316 · Data updated 2026-11-12
This study looks at how patients with rare genetic syndromes like Prader-Willi and Klinefelter manage their health as they move from children's care to adult care to see what support they need.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 1 site (Rotterdam, South Holland) |
| Status | Recruiting |
| Started | October 1, 2018 |
| Main results expected | January 1, 2030 |
| Study ends | January 1, 2030 |
| Registry record updated | September 6, 2023 |
| Trial ID | NCT04463316 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with rare genetic syndromes attending the multidisciplinary outpatient clinic at Erasmus Medical Center.
✕Probably not a fit
Patients with common genetic disorders or those not receiving care at the specified clinic may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on patients with rare genetic syndromes, such as Prader-Willi Syndrome and Klinefelter Syndrome, who receive multidisciplinary care at a specialized outpatient clinic. The study aims to assess the complexities of managing these syndromes as patients transition from pediatric to adult care, highlighting the need for coordinated health management to address ongoing medical issues. By analyzing patient files, the study seeks to improve understanding of the long-term care needs of individuals with these conditions.
Why it matters
Potential benefit: If successful, this study could enhance the quality of care and health outcomes for adults with rare genetic syndromes.
How similar studies have gone: While there may be limited studies focusing specifically on adult care for these syndromes, the approach of multidisciplinary management has shown promise in related fields.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with rare syndromes or rare congenital diseases visiting the multidisciplinary outpatient clinic for patients with rare diseases at the department of endocrinology, internal medicine, Erasmus Medical Center. Exclusion Criteria: * None
Where it's running
-
Erasmus Medical Center
Rotterdam, South Holland, Netherlands Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for Rare Diseases
This study is creating a detailed registry to collect information on rare diseases like amyloidosis and sarcoidosis to help improve how they are diagnosed and treated.
-
Comparing Sertraline and Placebo for Treating Anxiety in Children with Neurodevelopmental Disorders
This study is testing if the medication sertraline can help reduce anxiety in children and teens aged 8-17 with neurodevelopmental disorders like autism and Fragile X syndrome compared to a placebo.
-
National Registry for Noonan Syndrome (Italy)
This registry will collect genetic and clinical information from people with Noonan syndrome in Italy to understand how the condition changes over time and how treatments like growth hormone may work.
-
Neuroradiology Features in Noonan Syndrome and Gene-Linked Brain Differences
This study tests brain MRI and MR angiography in people with Noonan syndrome to see how brain imaging patterns relate to their specific genetic mutations.
-
Setmelanotide in BBS and related genetic obesity: real-world effects
This study tests how well Setmelanotide works and is tolerated in people with Bardet-Biedl syndrome or similar genetic obesity conditions in routine clinical care.
-
Inpegsomatropin vs Givopegsomatropin for short stature in girls with Turner syndrome
A 52-week, multicenter, randomized study tests whether Inpegsomatropin injections help prepubertal girls with Turner syndrome grow taller compared with a known treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.